Biogen price target raised to $387 from $343 at Citigroup

theflyonthewall.com

Citigroup raised its price target for Biogen shares to $387 citing the company's earnings and revenue growth following its better than expected Q2 results. Citi keeps a Buy rating on the stock.

View Comments (0)